A bipartisan effort to increase transparency in the healthcare system moved forward on Wednesday after the Senate Committee on Health, Education, Labor, and Pensions voted to advance the Patients Deserve Price Tags Act. The legislation, introduced by Sens. Roger Marshall (R-Kan.) and John Hickenlooper (D-Colo.), would expand existing federal price transparency requirements for hospitals and health insurers. It would also place many of those rules into federal law.

If enacted, hospitals would be required to publish the actual prices patients can expect to pay for medical services in clear, consumer-friendly language instead of relying on estimates or pricing formulas. The bill would also require hospitals to provide itemized bills within 30 days. That would allow patients to compare their final charges with the prices they were shown beforehand.

The proposal would also strengthen transparency requirements for health insurers by requiring them to continue publishing negotiated rates while shielding patients from financial responsibility if an insurer’s online cost estimates end up being inaccurate. Third-party administrators would also be required to provide self-insured employers with greater access to claims data.

That would enable them to better evaluate healthcare spending and compare insurance options. Those in support of the proposal believe it would encourage competition while reducing healthcare costs. Conversely, hospital and insurance industry groups contend that the requirements will increase administrative burdens and fail to account for the complexity of medical billing.

Hospital prices often remain unclear until after treatment. That leaves patients unable to compare costs or accurately judge what they may owe. Requiring hospitals to publish their actual prices rather than often inaccurate estimates would make it easier to compare the costs of procedures, imaging, lab work, and services before scheduling care. Itemized bills would also give patients an easier way to identify duplicate charges, mistakes, or amounts that exceed the price provided in advance…

With the NASDAQ ticker FASF reserved and ground broken on their flagship coal reformation facility, Frontieras is hitting massive milestones at a rapid pace.*

This positions the company for potential valuation impact as they reform coal into $2.1T worth of high-value commodities with their patented FASForm technology: 

You have until August 6 to invest in Frontieras at the current share price of $9.01/share.

The bill could also give employers greater leverage over healthcare spending, as most workers with employer-sponsored insurance are covered through self-insured plans. Yet third-party administrators often control the claims data employers need to evaluate costs.

Greater access could help companies negotiate better contracts or change providers. Still, the proposal will likely be difficult to implement, as hospitals argue that final charges often change due to complications, additional treatment, and delayed insurance decisions.

Greater price transparency would make it easier to plan for medical expenses before treatment and identify billing problems afterward. With hospitals required to publish actual prices, comparing the cost of imaging, laboratory work, outpatient procedures, and other services could become a more practical part of choosing where to receive care. It would also allow you to verify expected out-of-pocket costs with your insurer in advance.

Once treatment is complete, detailed itemized bills would provide a clearer way to identify billing errors, question unexpected charges, and dispute costs that differ significantly from the prices originally provided.

However, even if the law is implemented, it would not guarantee lower healthcare costs. Everything from emergency treatment and unexpected complications to insurance deductibles could still leave patients with expensive bills. That makes it important to review both price information and final charges carefully.

*Disclaimer: This is a paid advertisement for Frontieras’s Regulation A offering. Please read the offering circular at https://invest.frontieras.com/

Reservation of the ticker symbol is not a guarantee that we will be listed on the NASDAQ. Listing on the NASDAQ is subject to approvals.

Under Regulation A+, a company has the ability to change its share price by up to 20%, without requalifying the offering with the SEC.